A Virginia teacher has filed a lawsuit saying he was

New Post Public Reply Private Reply Replies (0) Message Board
PoemStone
109
A Virginia teacher has filed a lawsuit saying he was wrongfully
fired for refusing to use male pronouns for a transgender student.
< >

A Virginia teacher has filed a lawsuit saying he was wrongfully fired for refusing to use male pronouns for a transgender student.

In 2018, a student at West Point High School began identifying as male. He and his mother asked for him to be referred to with his preferred name and pronouns: he, him, his.

French teacher Peter Vlaming said he couldn’t “in good conscience” comply, citing his religious beliefs, according to the complaint. He consistently used the student’s preferred male name and attempted to avoid the use of any pronouns at all, his lawsuit says.

The school, according to the lawsuit, gave the teacher an ultimatum: Use the student’s preferred pronouns or lose your job.

School officials suspended the teacher for insubordination. Vlaming was ultimately fired after he refused to use the male pronouns and for repeatedly ignoring orders from his bosses.

“Mr. Vlaming’s conscience and religious practice prohibits him from intentionally lying, and he sincerely believes that referring to a female as a male by using an objectively male pronoun is telling a lie,” the lawsuit argues.

CNN has reached out to West Point Public Schools for comment and has not heard back. The school is about 40 miles east of Richmond.

A spokesperson for West Point Public Schools said in a statement to The Washington Post that its board denies any wrongdoing. “West Point Public Schools’ primary focus is on students, staff, and instruction,” the spokesperson said. “We will continue to direct our energy toward maintaining a high-quality learning environment in our schools.”

Vlaming worked with the district for seven years. The decision to fire the teacher came after a virtual reality exercise in the classroom, where Vlaming called out, “Don’t let her hit the wall!” as the transgender student walked in that direction, the lawsuit states.

The student waited for all the students to leave class that day before approaching the teacher, the lawsuit says.

“Mr. Vlaming, you may have your religion,” the student said, according to the suit, “but you need to respect who I am!”

Vlaming said it was an unintentional slip of the tongue.

School officials said the educator was insubordinate and failed to follow directives from administrators. And, officials said, the teacher could not be allowed to treat the transgender student differently.

“That discrimination then leads to creating a hostile learning environment. And the student had expressed that,” Superintendent Laura Abel told the Richmond Times-Dispatch late last year. “The parent had expressed that. They felt disrespected.”

The firing led to petitions as well as a student walkout in support of Vlaming. Students held signs saying “men are men and women are women” and “facts don’t care about your feelings,” CNN affiliate WWBT in Richmond reported at the time.

The former teacher is now suing the school district officials, saying they breached his contract and discriminated against him, violating his right to speak freely and his religious freedom. He is seeking $500,000 in lost wages and benefits, plus $500,000 for loss of reputation, pain, suffering and emotional distress. He is asking to get his job back or another position at equal or higher pay.

“This isn’t just about a pronoun, it’s about what that pronoun means,” Tyson Langhofer, director of the ADF Center for Academic Freedom, said in a statement. “This was never about anything Peter said or did; only about what the school was demanding he say. Nobody should be forced to contradict his core beliefs just to keep a job.”

The University of Wisconsin-Milwaukee’s Lesbian, Gay, Bisexual, Transgender Resource Center has previously talked about the importance of pronouns in referring to transgender people. “It is a privilege to not have to worry about which pronoun someone is going to use for you based on how they perceive your gender,” its website says. “If you have this privilege, yet fail to respect someone else’s gender identity, it is not only disrespectful and hurtful, but also oppressive.”


Featured stocks: Coffee Shoppe
For conservative debate: "Keeping it Real"
Game Changing stock $SHMP

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Innovent's SINTBILO® Hits Primary Endpoint in Study

Updated Category News Views 119

Innovent's Latest Breakthrough with SINTBILO® One moment you're sipping coffee, the next you're staring at a clinical milestone. Innovent Biologics has shouted from the rooftops that their drug, SINTBILO® (tafolecimab injection), has wrapped up its Phase 3 CREDIT-5 study, snagging the primary endpoint with both hands. This isn't just any drug; it's marked as the first...

Continue Reading
Stavian Group Eyes AI-Driven Southeast Asia Growth

Updated Category News Views 50

AI and Infrastructure: A New Chapter for Southeast Asia What does Southeast Asia's future look like with AI steering the ship? Well, there's a fresh breeze of change blowing, and right at the heart of it stands Stavian Group. At the recently held inaugural Fortune SEA500 Summit in Ho Chi Minh City, this conglomerate threw its hat into the ring, painting a vision of growth...

Continue Reading
Intelligent Communication Forum Eyes Global Ecosystem Shift

Updated Category News Views 612

China's Grand Vision for Intelligent Communication You know what they say about big ideas—they start in the most bustling of places. And here we are in Wuxi, a city's pulse pounding with ambition, hosting the 2026 China International Intelligent Communication Forum. Picture it: From November 8th to 10th, movers, shakers, and visionaries are scribbling new blueprints for...

Continue Reading
Antengene’s AnTenGager-D2 Advances in Cancer Treatment

Updated Category News Views 56

Antengene's AnTenGager-D2 Offers Fresh Hope Alright, let's dig into the latest buzz from the 2026 Society for Immunotherapy of Cancer conference about Antengene's AnTenGager-D2 platform. If you're not into biotech lingo, buckle up, because this is a ride into the future of cancer treatments—where science fiction might soon become science fact. A Novel Approach to Tumor...

Continue Reading
D-Wave's Legal Trouble: Securities Fraud Suit Looms

Updated Category News Views 351

A Looming Legal Storm for D-Wave Investors Call it another day, another legal tangle in the investing world. This time, it's D-Wave Quantum Inc. (NASDAQ: QBTS) on the receiving end of a securities fraud class action lawsuit. Yeah, those fancy quantum computers they're pushing didn't predict this one coming. The legal arena is getting ready for a bout, and if you've got...

Continue Reading
CureGene's Evategrel Aims for Breakthrough in Stroke Care

Updated Category News Views 69

Revolutionizing Stroke Care: Enter Evategrel When it comes to strokes, time is money—and I'm telling you, this ain't an area where you can afford to twiddle your thumbs. The faster you can get that blood flowing again, the better the chance you've got of walking away with less damage. That's where CureGene's new investigational drug, Evategrel, comes in. Why Evategrel...

Continue Reading
Allergan Aesthetics Study Shows Rising Patient Satisfaction

Updated Category News Views 344

Enhanced Patient Satisfaction with Aesthetic Treatments Dive into the latest studies from Allergan Aesthetics—AbbVie's heavyweight in the beauty battleground. If you've got an ounce of optimism left in this market, their recent findings might just lift your spirits. Phase 4 studies, namely HARMONY IN DIVERSITY and HALO, are showing highly positive results among patients...

Continue Reading
Gildan's Crisis: Investors Face Losses Amid Lawsuit

Updated Category News Views 245

Gildan Investors, Brace Yourself Poor old Gildan Activewear finds itself in hot water again, with a class action lawsuit cropping up like an unexpected storm on farmers' day. Any traders remotely involved with NYSE:GIL should pay damn close attention, because with a December 14, 2026 deadline looming, it's crunch time. The Root of the Lawsuit The plot thickens here,...

Continue Reading
JNJ's Dual-Antigen Therapy Shows Promise in Prostate Cancer

Updated Category News Views 273

Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...

Continue Reading
GlycoNex Eyes Japanese Market with Denosumab Biosimilar

Updated Category News Views 84

A Strategic Step into the Japanese Market Alright folks, there's a new kid aiming to shake things up in the biotech neighborhood, and it's GlycoNex with its denosumab biosimilar, SPD8. These guys just tossed their hat in the ring with a regulatory submission to Japan's Pharmaceuticals and Medical Devices Agency (PMDA). If the cosmic forces align, they might snag an...

Continue Reading

Top 5 Most Recently Viewed Articles

Equitage Ventures Launches $47.3M Fund for Senior Care Tech

Updated Category News Views 329

Equitage Ventures Launches Significant Investment Fund Equitage Ventures, an early-stage venture capital firm dedicated to AgeTech, has announced the successful final closing of a substantial $47.3 million investment fund. This fund is designed to provide critical capital, distribution resources, and strategic guidance to innovative entrepreneurs who aim to tackle the...

Continue Reading
Understanding Market Trends: Insights into Chevron Corp's Performance

Updated Category News Views 171

Chevron Corp Market Sentiment Analysis Chevron Corp (NYSE: CVX) has experienced a noteworthy decline in its short interest as a percentage of float, showing a 10.26% decrease since its previous report. Currently, there are approximately 14.02 million shares sold short, which accounts for 0.7% of all shares available for trading. Given the trading volume, it is estimated...

Continue Reading
Establishment of Blakely McCrory Hope Fund at Moody Gardens

Updated Category News Views 200

Introducing the Blakely McCrory Hope Fund Moody Gardens is proud to announce a special initiative to honor the memory of a young girl who captured the hearts of many: the Blakely McCrory Hope Fund. This fund has been established in loving memory of 8-year-old Blakely McCrory, who lost her life in a tragic flooding incident that occurred during the summer months....

Continue Reading
Star-Studded Table Read of 'It's a Wonderful Life' Event

Updated Category News Views 221

Exciting Holiday Table Read for a Worthy Cause The Ed Asner Family Center is pulling out all the stops this holiday season with an exciting virtual table read of the beloved classic, "It's a Wonderful Life." Scheduled for December 14 at 5 PM PST, this event promises to spread joy while supporting individuals and families with special needs. Star-Studded Cast Comes...

Continue Reading
Transforming $100 Into Over $1700 with Monolithic Power Systems

Updated Category News Views 145

Understanding the Growth of Monolithic Power Systems Monolithic Power Systems (NASDAQ: MPWR) has showcased impressive financial performance over the past decade, outperforming many market benchmarks. With an impressive annualized growth rate of 19.88%, it has attracted the attention of savvy investors. The Power of Compounded Returns Imagine investing $100 in MPWR stock...

Continue Reading